In APL with the classic reciprocal translocation t (15; 17) (q22; q21) which is characterized by fusion gene transcript PML-RAR-alpha, patients are responsive to differentiation treatment with all-trans retinoic acid (ATRA) [13]. This evidence concerns the gene RARA and acute promyelocytic leukemia.